Highlights in NSCLC from the 2014 American Society of Clinical Oncology annual meeting

Clin Adv Hematol Oncol. 2014 Oct;12(10 Suppl 18):7-16.
No abstract available

Publication types

  • Congress

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / genetics
  • Clinical Trials as Topic
  • ErbB Receptors / genetics
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / genetics
  • Mutation / genetics

Substances

  • Antineoplastic Agents
  • ErbB Receptors